Cipro and Innohep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro and Innohep. Common interactions include chest pain among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people who take Cipro and Innohep have. It is created by eHealthMe based on reports of 14 people who take Cipro and Innohep from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

14 people who take Cipro and Innohep together, and have interactions are studied.


What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 31,655 Cipro users for its effectiveness, alternative drugs and more.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 8,216 Innohep users for its effectiveness, alternative drugs and more.

Number of Cipro and Innohep reports submitted per year:

Cipro and Innohep drug interactions.

Common Cipro and Innohep drug interactions by gender *:

female:

  1. Chest pain
  2. Crohn's disease
  3. Decreased activity
  4. Feeling of body temperature change
  5. Headache
  6. Heart rate increased
  7. Hiatus hernia
  8. Hypoaesthesia
  9. Infusion related reaction
  10. Jaundice

male:

  1. Drug hypersensitivity
  2. Toxic epidermal necrolysis
  3. Cytolytic hepatitis

Common Cipro and Innohep drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug hypersensitivity
  2. Toxic epidermal necrolysis
  3. Crohn's disease
  4. Cytolytic hepatitis
  5. Decreased activity
  6. Feeling of body temperature change
  7. Headache
  8. Heart rate increased
  9. Hiatus hernia
  10. Hypoaesthesia

60+:

n/a

Common conditions people have *:

  1. Ill-Defined Disorder: 7 people, 50.00%
  2. Pneumonia: 7 people, 50.00%
  3. Diabetes: 6 people, 42.86%
  4. Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 42.86%
  5. Breast Cancer: 3 people, 21.43%
  6. Vulvovaginal Dryness: 1 person, 7.14%
  7. Anorectal Disorder: 1 person, 7.14%
  8. Bone Disorder: 1 person, 7.14%
  9. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 7.14%
  10. Fever: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Innohep?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cipro and Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cipro side effects:

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Innohep side effects:

Browse all side effects of Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cipro interactions:

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Innohep interactions:

Browse all interactions between Innohep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and tinzaparin sodium (the active ingredients of Cipro and Innohep, respectively), and Cipro and Innohep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cipro and Innohep.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: